GE Healthcare has partnered with healthcare technology supplier Wego Pharmaceutical to manufacture single-use consumables for bioprocessing in Weihai, China.
The collaboration aims to slash product delivery times for Chinese biopharmaceutical companies, enhance customer support locally and increase their access to a wide range of standard and custom single-use products to help them bring therapeutics to patients faster.
The first single-use consumables produced at Wego’s manufacturing facility will be available later this month, with continued offerings throughout 2019.
All products will be manufactured using Fortem, GE Healthcare’s materially advanced, single-use platform film, which simplifies the customer validation and approval processes by incorporating GE’s full range of bioprocessing systems.
“We are excited to play a critical role within the Chinese biopharma industry by ensuring efficient lead times and security of supply, which ultimately helps the local manufacturers to serve patients faster,” said Olivier Loeillot, General Manager, BioProcess, GE Healthcare Life Sciences.
“China continues to lead in the adoption of innovative single-use biomanufacturing solutions, including GE Healthcare’s end-to-end biomanufacturing solutions KUBio and FlexFactory.
“This highlights that China has a large installed space coupled with a strong biopharma pipeline predominantly based on single-use technologies.”
The Chinese biopharma market grew 8% in 2017 and the estimated annual growth rate for monoclonal antibodies is over 25% for the coming years.